Ask AI

ClinicalThought

Share

Program Content

Activities

  • PI3K/AKT Inhibitors in mBC
    Novel Targeted Therapies for PIK3CA/AKT1/PTEN-Altered Metastatic Breast Cancer: Key Evidence and Real-world Insights to Optimize Patient Care
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 29, 2025

  • PI3K/AKT-hämmare i metastatisk bröstcancer
    Nya riktade behandlingar för metastatisk bröstcancer med PIK3CA/AKT1/PTEN-förändringar: Viktig evidens och insikter från klinisk praxis för att optimera patientvården
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 13, 2025

  • Inibidores de PI3K/AKT no mBC
    Novas terapias direcionadas para o cancro da mama metastático com alterações em PIK3CA/AKT1/PTEN: evidências importantes e insights do mundo real para otimizar o tratamento de doentes
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 13, 2025

  • PI3K/AKT-Inhibitoren bei mbH (metastasierter Brustkrebs)
    Neue zielgerichtete Therapien bei PIK3CA/AKT1/PTEN-verändertem metastasiertem Brustkrebs: Zentrale Evidenz und Erkenntnisse aus der Versorgungspraxis (Real-World-Daten) zur Optimierung der Patientenversorgung
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 15, 2025

  • Inibitori di PI3K/AKT nel mBC
    Nuove terapie mirate per il carcinoma mammario metastatico con alterazioni dei geni PIK3CA/AKT1/PTEN: prove determinanti e approfondimenti dal mondo reale per ottimizzare la cura dei pazienti
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 16, 2025

  • Inhibiteurs de PI3K/AKT dans le cancer du sein métastatique
    Nouveaux traitements ciblés pour le cancer du sein métastatique avec altération des gènes PIK3CA/AKT1/PTEN : des preuves essentielles et des informations concrètes pour optimiser les soins
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 16, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd.